Balance Sheet Data

Ekso Bionics Holdings, Inc. (EKSO)

$1.75

-0.01 (0.00%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 7.6610.8712.8640.4120.5322.3523.9225.6027.3929.31
Total Cash (%)
Account Receivables 3.665.213.394.664.635.125.485.866.276.71
Account Receivables (%)
Inventories 3.372.491.982.245.193.593.844.114.404.71
Inventories (%)
Accounts Payable 3.161.901.503.113.153.053.273.503.744
Accounts Payable (%)
Capital Expenditure -0.13-0.06-0.07-0.09-0.10-0.11-0.12-0.13-0.13-0.14
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.